Regulations, Generics, and Disruptive Technologies in Ophthalmology: What Every Scientist Needs to Know

J Ocul Pharmacol Ther. 2021 Apr;37(3):141. doi: 10.1089/jop.2021.29078. Epub 2021 Mar 17.

Authors

Cheryl L Rowe-Rendleman¹, Randolph D Glickman²

Affiliations

¹ Omar Consulting Group, LLC, Durham, North Carolina, USA.
² Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.

PMID: 33733867
DOI: 10.1089/jop.2021.29078

No abstract available

MeSH terms

Disruptive Technology*
Drugs, Generic / therapeutic use*
Eye Diseases / drug therapy*
Humans
Ophthalmology
Physicians

Substances

Drugs, Generic